| 1 | 0,5 mg Fingolimod (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 2 | FINGOLIMOD (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 14, 156 💬
|
| 3 | Fingolimod (FTY720) (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 156 💬
|
| 4 | Fingolimod 0.5 mg (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 5 | Fingolimod 0.5mg (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 6 | Fingolimod 1.25 mg (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 7 | FINGOLIMOD HYDROCHLORIDE (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬
|
| 8 | Hidrocloruro de fingolimod (D04187) | [1] Fingolimod Fingolimod | [3] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Fingolimod
,
Fingolimod lauryl sulfate
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬
|
| 9 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (D04187) | [12] Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | [13] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
,
Dimethyl fumarate
,
Fingolimod hydrochloride
(D04187),
Glatiramer acetate
,
Ocrelizumab
,
Natalizumab
,
Ofatumumab
,
Fingolimod
,
Teriflunomide
,
Ponesimod
,
Fingolimod lauryl sulfate
💬
| [26] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬
| [58] Allograft rejection Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 13 13 💬
|
| 10 | Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod (D04187) | [7] Acetate Acetate, Fingolimod, Glatiramer, Ozanimod, Ponesimod, Siponimod, Teriflunomide | [10] Fingolimod hydrochloride
Fingolimod hydrochloride
(D04187),
Glatiramer acetate
,
Fingolimod
,
Teriflunomide
,
Ozanimod hydrochloride
,
Ozanimod
,
Siponimod fumarate
,
Ponesimod
,
Siponimod
,
Fingolimod lauryl sulfate
💬
| [26] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [37] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|